Patents by Inventor Qingqin Li

Qingqin Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9605317
    Abstract: The present invention provides methods for identifying patients at increased risk of developing an adverse neurological event in response to a cancer treatment. Methods also include modifying the treatment regimen of said patent dependent on the presence or absence of biomarkers in the patient.
    Type: Grant
    Filed: March 24, 2010
    Date of Patent: March 28, 2017
    Assignee: Janssen Pharmaceutica NV
    Inventors: Nadine Cohen, Reyna Favis, Qingqin Li, Deborah Ricci, Yu Sun, Helgi van de Velde
  • Publication number: 20100249065
    Abstract: The present invention provides methods for identifying patients at increased risk of developing an adverse neurological event in response to a cancer treatment. Methods also include modifying the treatment regimen of said patent dependent on the presence or absence of biomarkers in the patient.
    Type: Application
    Filed: March 24, 2010
    Publication date: September 30, 2010
    Inventors: Nadine Cohen, Reyna Favis, Qingqin Li, Deborah Ricci, Yu Sun, Helgi van de Velde
  • Publication number: 20040126777
    Abstract: Isolated nucleic acid molecules encoding polypeptides from a human, reagents related thereto (including purified polypeptidesspecific antibodies) are provided. Methods of using said reagentsand diagnostic kits are also provided.
    Type: Application
    Filed: July 25, 2003
    Publication date: July 1, 2004
    Inventors: Ramesh Rajani Bhatt, John Nels Calley, Josef Georg Heuer, Gerald Patrick Keleher, Joanne Sloan Lancaster, Qingqin Li, Deshun Lu, Bradley Jay Mills, Santosh Kumar Mishra, Douglas Raymond Perkins, Scott William Rowlinson, Rosamund Carol Smith, Eric Wen Su, He Wang, Yu Zhi